The seminar addressed current and future EU legal and regulatory developments relevant to cell-based therapies. In particular, the seminar focused on how to choose and support the right regulatory pathway for a product and seeing that through on a multinational basis.

Speakers and their presentations:

Eliane Schutte, Signifix: Advanced Therapy Medicinal Products;

Carine van den Brink, Axon Lawyers: Latest Developments in Biotech Patents;

Alex Denoon, Denoon Legal & Erik Vollebregt, Axon Lawyers: Cell Based Therapies Legal & Regulatory